{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:50:45Z","timestamp":1787957445685,"version":"build-2784847793"},"reference-count":47,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Microbiology"],"published-print":{"date-parts":[[2014,1,1]]},"DOI":"10.3402\/jom.v6.26156","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T07:34:31Z","timestamp":1417678471000},"page":"26156","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Salivary concentration of the antimicrobial peptide LL-37 in patients with oral lichen planus"],"prefix":"10.1080","volume":"6","author":[{"given":"Sotiria","family":"Davidopoulou","sequence":"first","affiliation":[{"name":"Department of Preventive DentistryPeriodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haris","family":"Theodoridis","sequence":"additional","affiliation":[{"name":"Department of Preventive DentistryPeriodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Nazer","sequence":"additional","affiliation":[{"name":"Department of Preventive DentistryPeriodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftichia","family":"Kessopoulou","sequence":"additional","affiliation":[{"name":"Department of Preventive DentistryPeriodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Menexes","sequence":"additional","affiliation":[{"name":"Department of Labor of AgronomySchool of Agriculture, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Kalfas","sequence":"additional","affiliation":[{"name":"Department of Preventive DentistryPeriodontology and Implant Biology, Dental School, Aristotle University of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,12,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","unstructured":"Di Stasio D, Guida A, Salerno C, Contaldo M, Esposito V, Laino L, etal. Oral lichen planus: a narrative review. Front Biosci (Elite Ed). 2014; 6: 370\u20136.","DOI":"10.2741\/e712"},{"key":"CIT0002","doi-asserted-by":"crossref","unstructured":"Schlosser BJ. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010; 23: 251\u201367.","DOI":"10.1111\/j.1529-8019.2010.01322.x"},{"key":"CIT0003","doi-asserted-by":"crossref","unstructured":"McCartan BE, Healy CM. The reported prevalence of oral lichen planus: a review and critique. J Oral Pathol Med. 2008; 37: 447\u201353.","DOI":"10.1111\/j.1600-0714.2008.00662.x"},{"key":"CIT0004","doi-asserted-by":"crossref","unstructured":"Ismail SB, Kumar SKS, Zain RB. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci. 2007; 49: 89\u2013106.","DOI":"10.2334\/josnusd.49.89"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1177\/154411130201300405"},{"key":"CIT0006","doi-asserted-by":"crossref","unstructured":"Ikeda N, Ishii T, Iida S, Kawai T. Epidemiological study of oral leukoplakia based on mass screening for oral mucosal diseases in a selected Japanese population. Community Dent Oral Epidemiol. 1991; 19: 160\u20133.","DOI":"10.1111\/j.1600-0528.1991.tb00133.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0528.1987.tb00480.x"},{"key":"CIT0008","doi-asserted-by":"crossref","unstructured":"Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus \u2013 a review. J Oral Pathol Med. 2010; 39: 729\u201334.","DOI":"10.1111\/j.1600-0714.2010.00946.x"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand. 2001; 59: 174\u20137.","DOI":"10.1080\/000163501750266774"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003; 3: 710\u201320.","DOI":"10.1038\/nri1180"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010; 87: 79\u201392.","DOI":"10.1189\/jlb.0609382"},{"key":"CIT0012","doi-asserted-by":"crossref","unstructured":"Zasloff M. Innate immunity, antimicrobial peptides, and protection of the oral cavity. Lancet. 2002; 360: 1116\u201317.","DOI":"10.1016\/S0140-6736(02)11239-6"},{"key":"CIT0013","unstructured":"Dale BA, Fredericks LP. Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol. 2005; 7: 119\u201333. [PubMed Abstract] [PubMed CentralFull Text]."},{"key":"CIT0014","doi-asserted-by":"crossref","unstructured":"Sorensen OE. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood. 2001; 97: 3951\u20139.","DOI":"10.1182\/blood.V97.12.3951"},{"key":"CIT0015","doi-asserted-by":"crossref","unstructured":"Murakami M, Ohtake T, Dorschner RA, Gallo RL. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res. 2002; 81: 845\u201350.","DOI":"10.1177\/154405910208101210"},{"key":"CIT0016","doi-asserted-by":"crossref","unstructured":"Bachrach G, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, etal. Salivary LL-37 secretion in individuals with Down syndrome is normal. J Dent Res. 2006; 85: 933\u20136.","DOI":"10.1177\/154405910608501012"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, etal. Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother. 2005; 49: 3883\u20138.","DOI":"10.1128\/AAC.49.9.3883-3888.2005"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Davison G, Allgrove JE, Gleeson M. Salivary antimicrobial peptides (LL-37 and alpha-defensins HNP1-3), antimicrobial and IgA responses to prolonged exercise. Eur J Appl Physiol. 2009; 106: 277\u201384.","DOI":"10.1007\/s00421-009-1020-y"},{"key":"CIT0019","doi-asserted-by":"crossref","unstructured":"Usui T, Yoshikawa T, Orita K, Ueda SY, Katsura Y, Fujimoto S, etal. Changes in salivary antimicrobial peptides, immunoglobulin A and cortisol after prolonged strenuous exercise. Eur J Appl Physiol. 2011; 111: 2005\u201314.","DOI":"10.1007\/s00421-011-1830-6"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Puklo M, Guentsch A, Hiemstra PS, Eick S, Potempa J. Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol. 2008; 23: 328\u201335.","DOI":"10.1111\/j.1399-302X.2008.00433.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2009.080532"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O'Neal R, etal. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res. 2001; 36: 285\u201394.","DOI":"10.1034\/j.1600-0765.2001.360503.x"},{"key":"CIT0023","doi-asserted-by":"crossref","unstructured":"Woo J-S, Jeong JY, Hwang YJ, Chae SW, Hwang SJ, Lee H-M. Expression of cathelicidin in human salivary glands. Arch Otolaryngol Head Neck Surg. 2003; 129: 211\u201314.","DOI":"10.1001\/archotol.129.2.211"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Hosokawa I, Hosokawa Y, Komatsuzawa H, Goncalves RB, Karimbux N, Napimoga MH, etal. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin Exp Immunol. 2006; 146: 218\u201325.","DOI":"10.1111\/j.1365-2249.2006.03200.x"},{"key":"CIT0025","doi-asserted-by":"crossref","unstructured":"Frohm Nilsson M, Sandstedt B, S\u00f8rensen O, Weber G, Borregaard N, St\u00e5hle-B\u00e4ckdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with Interleukin-6. Infect Immun. 1999; 67: 2561\u20136. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1128\/IAI.67.5.2561-2566.1999"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, etal. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, beta-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother. 2005; 55: 888\u201396.","DOI":"10.1093\/jac\/dki103"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Ji S, Hyun J, Park E, Lee B-L, Kim K-K, Choi Y. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res. 2007; 42: 410\u201319.","DOI":"10.1111\/j.1600-0765.2006.00962.x"},{"key":"CIT0028","doi-asserted-by":"crossref","unstructured":"Bouzari N, Kim N, Kirsner RS. Defense of the skin with LL-37. J Invest Dermatol. 2009; 129: 814.","DOI":"10.1038\/jid.2009.37"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-009-0057-2"},{"key":"CIT0030","doi-asserted-by":"crossref","unstructured":"Nijnik A, Hancock REW. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol. 2009; 16: 41\u20137.","DOI":"10.1097\/MOH.0b013e32831ac517"},{"key":"CIT0031","doi-asserted-by":"crossref","unstructured":"Chamorro CI, Weber G, Gr\u00f6nberg A, Pivarcsi A, St\u00e5hle M. The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol. 2009; 129: 937\u201344.","DOI":"10.1038\/jid.2008.321"},{"key":"CIT0032","doi-asserted-by":"crossref","unstructured":"Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, etal. Identification of defensin-1, defensin-2, and CAP37\/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996; 271: 2935\u201340.","DOI":"10.1074\/jbc.271.6.2935"},{"key":"CIT0033","doi-asserted-by":"crossref","unstructured":"Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock REW. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J Immunol. 2002; 169: 3883\u201391.","DOI":"10.4049\/jimmunol.169.7.3883"},{"key":"CIT0034","doi-asserted-by":"crossref","unstructured":"Davidopoulou S, Diza E, Menexes G, Kalfas S. Salivary concentration of the antimicrobial peptide LL-37 in children. Arch Oral Biol. 2012; 57: 865\u20139.","DOI":"10.1016\/j.archoralbio.2012.01.008"},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"Davidopoulou S, Diza E, Sakellari D, Menexes G, Kalfas S. Salivary concentration of free LL-37 in edentulism, chronic periodontitis and healthy periodontium. Arch Oral Biol. 2013; 58: 930\u20134.","DOI":"10.1016\/j.archoralbio.2013.01.003"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11201-3"},{"key":"CIT0037","doi-asserted-by":"crossref","unstructured":"De Haar SF, Hiemstra PS, Van Steenbergen MTJM, Everts V, Beertsen W. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun. 2006; 74: 5284\u201391.","DOI":"10.1128\/IAI.02016-05"},{"key":"CIT0038","doi-asserted-by":"crossref","unstructured":"Mizukawa N, Sugiyama K, Ueno T, Mishima K, Takagi S, Sugahara T. Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral Dis. 1999; 5: 139\u201342.","DOI":"10.1111\/j.1601-0825.1999.tb00078.x"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2011.569045"},{"key":"CIT0040","doi-asserted-by":"crossref","unstructured":"Abiko Y, Jinbu Y, Noguchi T, Nishimura M, Kusano K, Amaratunga P, etal. Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. an immunohistochemical study. Pathol Res Pract. 2002; 198: 537\u201342.","DOI":"10.1078\/0344-0338-00298"},{"key":"CIT0041","doi-asserted-by":"crossref","unstructured":"Mumcu G, Cimilli H, Karacayli U, Inanc N, Ture-Ozdemir F, Eksioglu-Demiralp E, etal. Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Beh\u00e7et's disease. Arch Oral Biol. 2011; 57: 642\u20136.","DOI":"10.1016\/j.archoralbio.2011.11.003"},{"key":"CIT0042","doi-asserted-by":"crossref","unstructured":"Rad M, Hashemipoor MA, Mojtahedi A, Zarei MR, Chamani G, Kakoei S, etal. Correlation between clinical and histopathologic diagnoses of oral lichen planus based on modified WHO diagnostic criteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107: 796\u2013800.","DOI":"10.1016\/j.tripleo.2009.02.020"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1021\/ac050161r"},{"key":"CIT0044","first-page":"133","volume-title":"Statistical strategies for small sample research","author":"Mehta CR","year":"1999"},{"key":"CIT0045","doi-asserted-by":"crossref","unstructured":"Buttgereit F, Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids. 2002; 67: 529\u201334.","DOI":"10.1016\/S0039-128X(01)00171-4"},{"key":"CIT0046","doi-asserted-by":"crossref","unstructured":"Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol. 2010; 120: 76\u201385.","DOI":"10.1016\/j.jsbmb.2010.02.018"},{"key":"CIT0047","doi-asserted-by":"crossref","unstructured":"Kerzerho J, Wunsch D, Szely N, Meyer H-A, Lurz L, R\u00f6se L, etal. Effects of systemic versus local administration of corticosteroids on mucosal tolerance. J Immunol. 2012; 188: 470\u20136.","DOI":"10.4049\/jimmunol.1101405"}],"container-title":["Journal of Oral Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3402\/jom.v6.26156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T01:36:15Z","timestamp":1597714575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3402\/jom.v6.26156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1,1]]}},"alternative-id":["10.3402\/jom.v6.26156"],"URL":"https:\/\/doi.org\/10.3402\/jom.v6.26156","relation":{},"ISSN":["2000-2297"],"issn-type":[{"value":"2000-2297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zjom20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zjom20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}